Skip to content
Screener

LifeStance Health Group LFST Q2 2026 earnings

Reported August 6, 2026 · Before market open

Revenue$435.4MBeat by $20.8M
EPS$0.06Beat by $0.03
Revenue estimate$414.6M
EPS estimate$0.03
“This was an outstanding second quarter and first half of 2026 for LifeStance, as we delivered quarterly revenue growth of 26%, positive net income of $24 million, and Adjusted EBITDA margins of 15%. This momentum underscores the substantial growth opportunity ahead as we extend our reach into new geographies, broaden our specialty capabilities, and strengthen our differentiation through clinical excellence and measurable patient outcomes.”
Dave Bourdon

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$431.4M
EPS estimate$0.03

Financials

Q2 2026

Income statement

See full
Revenue$435.4M+26.1%
Operating income$30.7M+1,139%
Net income$23.6M+723%
EPS (diluted)$0.06+700%

Balance sheet

See full
Cash & equivalents$225.9M+19.6%
Total debt$474.2M0.0%
Total equity$1.5B+0.2%
Total assets$2.2B+1.6%

Cash flow

See full
Operating cash flow$99.9M+55.2%
CapEx$12.0M+54.7%
Free cash flow$87.9M+55.2%

Valuation & ratios

Valuation

as of 09/16/26
See full
Market cap$4.96B+144%
Enterprise value$5.21B+125%
P/E98.1×—
P/S3.1×+1.6×

Profitability

See full
Operating margin4.9%+4.9pp
Net margin3.2%+2.7pp
FCF margin11%+1.9pp

Returns & leverage

See full
Return on equity3.4%+3.0pp
Debt / equity0.3×0.0×
Current ratio1.4×-0.1×

FAQ

When did LifeStance Health Group report Q2 2026 earnings?
LifeStance Health Group (LFST) reported Q2 2026 earnings on August 6, 2026 before market open.
What were LifeStance Health Group's Q2 2026 revenue and EPS?
LifeStance Health Group reported revenue of $435.4M and eps of $0.06 for Q2 2026.
Did LifeStance Health Group beat estimates in Q2 2026?
Revenue beat the consensus estimate of $414.6M by $20.8M. EPS beat the consensus estimate of $0.03 by $0.03.
How did LifeStance Health Group's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 26.1% from $345.3M a year earlier.
Where can I find LifeStance Health Group's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-336057) and the 10-Q periodic report (0001193125-26-338107) directly on SEC EDGAR. The filing index links above go to sec.gov.